Les données ont montré que l’expression de PTK7 reste stable à travers les stades de la maladie et le statut métastatique, suggérant une pertinence potentielle tant dans les maladies précoces que ...

Berberine is not new. Extracted from plants such as barberry, goldenseal, and tree turmeric, it has a centuries-long history ...

While anti-VEGF therapies remain the current standard of care, many DME patients experience suboptimal responses due to ...

Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) ...

A new study has identified TRIM56, an E3 ubiquitin ligase, as a key activator of the proto-oncogene Src in hepatocellular ...

Scientists at the Ruđer Bošković Institute (RBI) in Zagreb, Croatia, have discovered that the protein CENP-E, long believed ...

Silmitasertib (CX-4945) is Senhwa's first-in-class CK2 inhibitor, currently under clinical development across multiple cancer indications. To date, the compound has been administered to hundreds of ...

< How the heart’s “energy shuttle” is built. The image shows the 3D shape of mitochondrial creatine ki ... Copyright: Anton Xu et al., Circulation, October 2025 ...

Study targets a key bottleneck in hit to lead optimisation by designing fragments that are both structurally diverse and easy ...

Immunosuppressive medications. Drugs like corticosteroids or azathioprine work by calming the immune system and reducing the ...

Pharming Group ( ($PHAR) ) just unveiled an update. On October 20, 2025, Pharming Group announced that 12 abstracts were accepted for presentation ...